PLC's laser heart surgery wins approval recommendation in the US nine months after initial failure
This article was originally published in Clinica
Executive Summary
An FDA advisory panel has unanimously recommended that the US agency approve PLC Systems' heart laser for transmyocardial revascularisation (TMR). Last July, the FDA's Circulatory System Devices Advisory Committee strongly rebuked PLC Systems, but the company emerged victorious from that same panel's review on April 24.